메뉴 건너뛰기




Volumn 157, Issue 9, 2000, Pages 1461-1466

Differentiating primary from secondary negative symptoms in schizophrenia: A study of neuroleptic-naive patients before and after treatment

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BIPERIDEN; HALOPERIDOL; HYPNOTIC AGENT; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE;

EID: 0033864933     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.157.9.1461     Document Type: Article
Times cited : (71)

References (24)
  • 4
    • 0032697694 scopus 로고    scopus 로고
    • Negative, parkinsonian, depressive and catatonic symptoms in schizophrenia: A conflict of paradigms revisited
    • (1999) Schizophr Res , vol.40 , pp. 245-253
    • Peralta, V.1    Cuesta, M.J.2
  • 12
    • 0008286005 scopus 로고
    • Scale for the Assessment of Positive Symptoms (SAPS). Iowa City, University of Iowa
    • (1984)
    • Andreasen, N.C.1
  • 13
    • 0008286006 scopus 로고
    • Modified Scale for the Assessment of Negative Symptoms (SANS). Iowa City, University of Iowa
    • (1984)
    • Andreasen, N.C.1
  • 22
    • 0033521616 scopus 로고    scopus 로고
    • Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo: A meta-analysis of randomized controlled trials
    • (1999) Schizophr Res , vol.35 , pp. 51-68
    • Leucht, S.1    Pitschel-Walz, G.2    Kissling, A.D.3
  • 24
    • 0008286887 scopus 로고
    • Negative Schizophrenic Symptoms: Pathophysiology and Clinical Implications. Washington, DC, American Psychiatric Press
    • (1991)
    • Greden, J.F.1    Tandon, R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.